Suchergebnisse - "Xia, Zhongjun"

PubPharm (7)

1

Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301) : a randomised, double-blinded, placebo-controlled, phase 3 trial

enthalten in: BMC cancer | 2023

von Xia, Z. | Leng, Y. | Fang, B. | +51

2

Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer

enthalten in: BMC cancer | 2016

von Sun, Y. | Cheng, Y. | Hao, X. | +16

3

Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer

enthalten in: BMC cancer | 2016

von Sun, Y. | Cheng, Y. | Hao, X. | +16

4

Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer

enthalten in: BMC cancer | 2016

von Sun, Y. | Cheng, Y. | Hao, X. | +16

5

Primary gastric non-Hodgkin's lymphoma in Chinese patients : clinical characteristics and prognostic factors

enthalten in: BMC cancer | 2010

von Huang, J. | Jiang, W. | Xu, R. | +7

6

Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors

enthalten in: BMC cancer | 2010

von Huang, J. | Jiang, W. | Xu, R. | +7

7

Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors

enthalten in: BMC cancer | 2010

von Huang, J. | Jiang, W. | Xu, R. | +7

1
[1]